Inactive Instrument

Daiichi Sankyo Company, Limited Share Price Other OTC

Equities

DSNKY

US23381D1028

Pharmaceuticals

Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site

Financials

Sales 2024 1,602B 10.29B 859B Sales 2025 * 1,767B 11.34B 947B Capitalization 9,964B 63.99B 5,342B
Net income 2024 201B 1.29B 108B Net income 2025 * 191B 1.23B 102B EV / Sales 2024 5.72 x
Net cash position 2024 * 556B 3.57B 298B Net cash position 2025 * 629B 4.04B 337B EV / Sales 2025 * 5.28 x
P/E ratio 2024
45.6 x
P/E ratio 2025 *
50.3 x
Employees -
Yield 2024
1.05%
Yield 2025 *
1.13%
Free-Float 97.04%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Daiichi Sankyo Company, Limited

Managers TitleAgeSince
Chief Executive Officer 69 01/07/01
President 61 01/17/01
Chief Tech/Sci/R&D Officer - 01/21/01
Members of the board TitleAgeSince
Director/Board Member 66 01/19/01
Director/Board Member 75 01/19/01
Chief Executive Officer 69 01/07/01
More insiders
Daiichi Sankyo Company specializes in developing, manufacturing and marketing pharmaceutical products. Net sales break down by activity as follows: - sale of medicines (99.8%): prescription medicines (92.8% of net sales) and OTC medicines (7.2%) primarily for the treatment of thrombotic disorders, tumors, diabetes and rheumatoid arthritis; - other (0.2%): primarily real estate activities. Net sales are distributed geographically as follows: Japan (64.1%), North America (17.2%), Europe (9.7%) and other (9%).
Related indices
More about the company
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW